Lexaria Bioscience (LEXX) Peer Comparison

$11.68

$0.64 (5.80%)

As on 27-Aug-2026 16:00EDT

Market cap

$18 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

4

Div. Yield

0 %

Edit

	Lexaria Bioscience (LEXX)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Market cap ($ Mln)	18	666	53,134
Revenue ($ Mln)	0	915	254,248
Net Profit ($ Mln)	-7.73	-122.57	1,714.00
Net Margin (%)	-3,985.58	-12.90	0.67
RoE (%)	-160.06	-6.65	-60.52
Price to Earnings	--	--	32.45
Price-To-Book	4.00	0.41	16.07

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Lexaria Bioscience (LEXX)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Operating Revenue	0.71	1,126.99	254,248.00
Cost of Revenue	0.00	796.88	244,474.00
Gross Profit	0.70	330.11	8,168.00
Operating Expenses	12.58	3,462.41	7,161.00
Operating Profit (EBIT)	-11.88	-3,132.30	2,613.00
Other Income	--	--	0.00
Profit before Tax	-11.91	-3,159.29	2,174.00
Provision for Tax	--	-166.06	469.00
Profit after Tax (Net Income)	-11.90	-3,000.62	1,714.00
Minority Interest	--	--	11.00
Consolidated Profit	--	--	917.00

Liabilities ($ Mln)

	Lexaria Bioscience (LEXX)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Shareholder's Funds	2.99	2,074.03	-2,883.00
Minority Interest	--	--	11.00
Non-Current Liabilities	0.08	475.86	16,119.00
Current Liabilities	1.49	384.63	43,904.00
Total Liabilities	4.18	2,904.47	53,122.00

Assets ($ Mln)

	Lexaria Bioscience (LEXX)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Non-Current Assets	0.71	1,959.54	18,546.00
Current Assets	3.47	944.93	38,753.00
Total Assets	4.18	2,904.47	53,122.00
Total Debt*	0.11	451.09	9,948.00
Net Current Assets	1.97	408.32	0.00

Cashflow ($ Mln)

	Lexaria Bioscience (LEXX)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Cash From Operating Activities	-10.45	-129.81	2,397.00
Cash Flow from Investing Activities	-0.24	-64.11	-5,605.00
Cash from Financing Activities	6.05	183.20	1,952.00
Net Cash Inflow / Outflow	--	--	--

Ratios

Profitability Ratios

	Lexaria Bioscience (LEXX)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
ROCE (%)	-211.16	-77.49	34.84
ROE (%)	-215.88	-88.71	-52.09
ROA (%)	-182.50	-68.11	1.82
EBIT Margin (%)	--	--	0.99
Net Margin (%)	-1,686.00	-266.25	0.67
Cash Profit Margin (%)	--	--	0.00

Growth Ratios

	Lexaria Bioscience (LEXX)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Revenue Growth (%)	0.52	0.05	14.23
EBIT Growth (%)	--	--	8.89
Net Profit Growth (%)	-105.37	-798.92	9.80
EPS Growth (%)	--	--	12.17
Book Value Growth (%)	--	--	-4.98

Valuation Ratios

	Lexaria Bioscience (LEXX)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Price / Earnings	--	--	25.83
Price / Book Value	--	--	-14.50
Dividend Yield (%)	--	--	--
EV/EBITDA	0.16	-0.03	14.74
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Lexaria Bioscience (LEXX)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Debt to Equity	0.04	0.22	0.00
Short term debt to equity ratio	0.01	0.02	-0.72
Current Ratio	2.32	2.46	0.88
Quick Ratio	--	1.49	0.49
Interest Coverage	--	-54.71	7.25

Operating Efficiency Ratios

	Lexaria Bioscience (LEXX)	Tilray Brands Inc. Class 2 (TLRY)	Cardinal Health (CAH)
Debtors to sales (%)	24.65	14.79	5.43
Asset Turnover	0.11	0.26	2.70
Receivable days	84.98	49.47	20.78
Inventory Days	0.08	163.90	27.08
Payable days	162,678.93	66.67	56.62
Cash Conversion Cycle	-48,458.59	146.70	-8.76

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly